Search research articles
Contact Us
Filters
Showing results (211-220 of 259) with videos related to
Page
of 26
Sort By:
Ophthalmology
|
November 3, 2015
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study
W Lloyd Clark, David S Boyer, Jeffrey S Heier, et al.
Ophthalmology
|
October 16, 2014
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study
Peter A Campochiaro, W Lloyd Clark, David S Boyer, et al.
American Journal of Ophthalmology
|
September 1, 2019
Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography
Wenying Fan, Muneeswar Gupta Nittala, Alan Fleming, et al.
Ophthalmology. Retina
|
September 23, 2019
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial
Charles C Wykoff, Muneeswar G Nittala, Brenda Zhou, et al.
Retina (Philadelphia, Pa.)
|
December 15, 2015
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics
Alexa L Li, Charles C Wykoff, Rui Wang, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
March 31, 2025
Genotypic and Phenotypic Characterization of <i>Hexokinase 1</i> p.Glu847Lys Variant Causing Autosomal Dominant Pericentral Retinitis Pigmentosa
Kenneth C Fan, Calvin W Wong, Braden A Nichols, et al.
American Journal of Ophthalmology
|
July 17, 2023
KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema
Charles C Wykoff, Justus G Garweg, Carl Regillo, et al.
Ophthalmology. Retina
|
May 4, 2019
Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies
Paul Mitchell, Ian McAllister, Michael Larsen, et al.
Ophthalmology. Retina
|
May 4, 2019
Outcomes of Diabetic Macular Edema Patients by Baseline Hemoglobin A1c: Analyses from VISTA and VIVID
Rishi P Singh, Charles C Wykoff, David M Brown, et al.
Ophthalmology
|
May 28, 2013
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE
David M Brown, Quan Dong Nguyen, Dennis M Marcus, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 259) with videos related to
Sort By:
Page
of 26
Ophthalmology
|
November 3, 2015
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study
W Lloyd Clark, David S Boyer, Jeffrey S Heier, et al.
Ophthalmology
|
October 16, 2014
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study
Peter A Campochiaro, W Lloyd Clark, David S Boyer, et al.
American Journal of Ophthalmology
|
September 1, 2019
Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography
Wenying Fan, Muneeswar Gupta Nittala, Alan Fleming, et al.
Ophthalmology. Retina
|
September 23, 2019
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial
Charles C Wykoff, Muneeswar G Nittala, Brenda Zhou, et al.
Retina (Philadelphia, Pa.)
|
December 15, 2015
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics
Alexa L Li, Charles C Wykoff, Rui Wang, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
March 31, 2025
Genotypic and Phenotypic Characterization of <i>Hexokinase 1</i> p.Glu847Lys Variant Causing Autosomal Dominant Pericentral Retinitis Pigmentosa
Kenneth C Fan, Calvin W Wong, Braden A Nichols, et al.
American Journal of Ophthalmology
|
July 17, 2023
KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema
Charles C Wykoff, Justus G Garweg, Carl Regillo, et al.
Ophthalmology. Retina
|
May 4, 2019
Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies
Paul Mitchell, Ian McAllister, Michael Larsen, et al.
Ophthalmology. Retina
|
May 4, 2019
Outcomes of Diabetic Macular Edema Patients by Baseline Hemoglobin A1c: Analyses from VISTA and VIVID
Rishi P Singh, Charles C Wykoff, David M Brown, et al.
Ophthalmology
|
May 28, 2013
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE
David M Brown, Quan Dong Nguyen, Dennis M Marcus, et al.
Page
of 26